Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
Implementing video-based group music therapy during cancer treatment: insights from a mixed-methods study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Grapp Miriam, Flock Charlotte, Friederich Hans-Christoph, Bugaj Till Johannes
Аннотация
PURPOSE: Music therapy is a beneficial supportive intervention in oncology. However, many patients undergoing cancer treatment face treatment-related physical impairments that limit participation in in-person sessions. This study explores the implementation of a video-based group music therapy intervention for patients undergoing tumour therapy.
METHODS: A mixed-methods, single-arm study was conducted with 40 adult cancer patients. The intervention consisted of eight 90-min video-based group music therapy sessions. Standardized questionnaires and open-ended questions were used pre- and post-intervention. Therapists provided structured feedback after each session. Evaluation was guided by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance).
RESULTS: Recruitment was efficient, with 40 of 44 screened patients enrolled. Attendance (90.1%) and completion (87.5%) rates were high. Participants rated the intervention as highly helpful (M = 4.77, SD = 0.49), with significant reductions in depression and anxiety (p < 0.001). In their feedback, patients frequently reported shared musical experiences and a sense of emotional closeness as particularly meaningful aspects of the sessions. Therapists observed strong group cohesion despite initial technical challenges. Follow-up data indicated continued use of music in daily life, suggesting lasting impact.
CONCLUSION: Video-based group music therapy is a feasible and well-accepted intervention for patients undergoing cancer treatment. It addresses access barriers due to treatment-related physical impairments and supports continuity of care. The intervention showed promising results across RE-AIM dimensions, including symptom relief and integration into everyday life. Further studies should assess efficacy and explore adaptations for specific patient subgroups.
TRIAL REGISTRATION: German Clinical Trials Register (DRKS00032339) (registered August 3, 2023).
METHODS: A mixed-methods, single-arm study was conducted with 40 adult cancer patients. The intervention consisted of eight 90-min video-based group music therapy sessions. Standardized questionnaires and open-ended questions were used pre- and post-intervention. Therapists provided structured feedback after each session. Evaluation was guided by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance).
RESULTS: Recruitment was efficient, with 40 of 44 screened patients enrolled. Attendance (90.1%) and completion (87.5%) rates were high. Participants rated the intervention as highly helpful (M = 4.77, SD = 0.49), with significant reductions in depression and anxiety (p < 0.001). In their feedback, patients frequently reported shared musical experiences and a sense of emotional closeness as particularly meaningful aspects of the sessions. Therapists observed strong group cohesion despite initial technical challenges. Follow-up data indicated continued use of music in daily life, suggesting lasting impact.
CONCLUSION: Video-based group music therapy is a feasible and well-accepted intervention for patients undergoing cancer treatment. It addresses access barriers due to treatment-related physical impairments and supports continuity of care. The intervention showed promising results across RE-AIM dimensions, including symptom relief and integration into everyday life. Further studies should assess efficacy and explore adaptations for specific patient subgroups.
TRIAL REGISTRATION: German Clinical Trials Register (DRKS00032339) (registered August 3, 2023).